Author

Ghodke-Puranik Y

Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai - Cited by 2,143

Biography

Dr. Ghodke Puranik Y , Studied in the Division of Rheumatology, Department of Immunology, Mayo Clinic, Rochester, Minnesota, Research interest are Rheumatology, Immunology       
Title
Cited by
Year
Valproic acid pathway: pharmacokinetics and pharmacodynamics
Y Ghodke-Puranik, CF Thorn, JK Lamba, JS Leeder, W Song, ...Pharmacogenetics and genomics, 2013201
376
2013
Immunogenetics of systemic lupus erythematosus: A comprehensive review
Y Ghodke-Puranik, TB NiewoldJournal of Autoimmunity, 2015201
247
2015
Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.
YG Puranik, AK Birnbaum, SE Marino, G Ahmed, JC Cloyd, RP Remmel, ...Pharmacogenomics 14 (1), 35-45, 2013201
117
2013
The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry
GN Goulielmos, MI Zervou, VM Vazgiourakis, Y Ghodke-Puranik, ...Gene 668, 59-72, 2018201
115
2018
CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus
MH Faridi, SQ Khan, W Zhao, HW Lee, MM Altintas, K Zhang, V Kumar, ...The Journal of clinical investigation 127 (4), 1271-1283, 2017201
97
2017
A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia
MJ Burke, JK Lamba, S Pounds, X Cao, Y Ghodke‐Puranik, BR Lindgren, ...American journal of hematology 89 (9), 889-895, 2014201
90
2014
Pathogenic citrulline‐multispecific B cell receptor clades in rheumatoid arthritis
PJ Titcombe, G Wigerblad, N Sippl, N Zhang, AK Shmagel, P Sahlström, ...Arthritis & rheumatology 70 (12), 1933-1945, 2018201
82
2018
Identification of suitable reference genes for hepatic microRNA quantitation
V Lamba, Y Ghodke-Puranik, W Guan, JK LambaBMC research notes 7, 1-10, 2014201
71
2014
Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.
SN Kariuki, Y Ghodke-Puranik, JM Dorschner, BS Chrabot, JA Kelly, ...Genes and Immunity, 2014201
61
2014
Genetics of the type I interferon pathway in systemic lupus erythematosus
Y Ghodke-Puranik, TB NiewoldInternational journal of clinical rheumatology 8 (6), 2013201
60
2013
Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis
Y Ghodke-Puranik, AS Puranik, P Shintre, K Joshi, B Patwardhan, ...Pharmacogenomics 16 (18), 2019-2034, 2015201
60
2015
microRNA-34a is associated with expression of key hepatic transcription factors and cytochromes P450
V Lamba, Y Ghodke, W Guan, TS TracyBiochemical and biophysical research communications 445 (2), 404-411, 2014201
55
2014
Lupus‐Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells
Y Ghodke‐Puranik, JM Dorschner, DM Vsetecka, S Amin, A Makol, ...Arthritis & Rheumatology 69 (12), 28-37, 2017201
23
2017
Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen
Y Ghodke-Puranik, M Imgruet, JM Dorschner, P Shrestha, K McCoy, ...Cytokine 132, 154631, 2020202
22
2020
PharmGKB summary: zidovudine pathway
Y Ghodke, PL Anderson, K Sangkuhl, J Lamba, RB Altman, TE KleinPharmacogenetics and genomics 22 (12), 891, 2012201
21
2012
Brief Report: A Novel ELANE Mutation Associated With Inflammatory Arthritis, Defective NETosis, and Recurrent Parvovirus Infection
U Thanarajasingam, MA Jensen, JM Dorschner, T Wampler Muskardin, ...Arthritis & Rheumatology 69 (12), 2396-2401, 2017201
16
2017
Innovative approaches in drug discovery: ethnopharmacology, systems biology and holistic targeting
B Patwardhan, R ChaguturuAcademic Press, 2016201
15
2016
Distinct single cell gene expression in peripheral blood monocytes correlates with tumor necrosis factor inhibitor treatment response groups defined by type i interferon in …
TL Wampler Muskardin, W Fan, Z Jin, MA Jensen, JM Dorschner, ...Frontiers in immunology , 1384, 2020202
11
2020
Type I interferon predicts an alternate immune system phenotype in systemic lupus erythematosus
U Thanarajasingam, AN Muppirala, MA Jensen, Y Ghodke‐Puranik, ...ACR Open Rheumatology 1 (8), 499-506, 2019201
11
2019
Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island
MI Zervou, JM Dorschner, Y Ghodke-Puranik, DT Boumpas, TB Niewold, ...Gene 6, 9-14, 2017201
10
2017

Referred From: https://scholar.google.com/citations?user=Z1m4AVsAAAAJ&hl=en

Cited by
Citations 2143
h-index 22
i10-index 29
Recommended Journals
Open Access Journals